세계의 산화 스트레스 어세이 시장 규모, 점유율, 성장 분석 : 제품별, 테스트 유형별, 기술별, 질환 유형별, 최종사용자별, 지역별 - 산업 예측(2025-2032년)
Oxidative Stress Assay Market Size, Share, and Growth Analysis, By Product (Consumables, Kits), By Test Type (Antioxidant Capacity Assays, Indirect Assays), By Technology, By Disease Type, By End User, By Region - Industry Forecast 2025-2032
산화 스트레스 어세이 세계 시장 규모는 2023년에 9억 4,500만 달러로 평가되었습니다. 또한, 2024년 10억 2,249만 달러에서 2032년에는 19억 2,078만 달러로 성장할 것으로 예상되며, 예측 기간(2025-2032년) 동안 8.2%의 연평균 복합 성장률(CAGR)을 나타낼 전망입니다.
세계 산화 스트레스 어세이 시장은 다양한 질병에서 산화 스트레스를 평가할 수 있는 효율적인 검사법에 대한 수요 증가에 힘입어 상승세를 보이고 있습니다. 이러한 성장의 주요 요인으로는 만성 질환의 유병률 증가, 조기 발견에 대한 인식 증가, 기술 발전 등이 있습니다. 또한, 개인 맞춤형 의료로의 전환과 신약 개발 과정에서의 산화 스트레스 어세이의 통합은 시장 확대를 더욱 촉진하고 있습니다. 주목할 만한 업계 기업들과 지속적인 연구 개발 노력이 이 분야를 강화하는 가운데, 현대 의료 진단 및 치료 전략에서 중요한 역할을 강조하면서 산화 스트레스 어세이 시장은 향후 몇 년동안 성장할 것으로 예상됩니다.
목차
서론
조사 방법
- 정보 조달
- 2차 데이터와 1차 데이터 방법
- 시장 규모 예측
- 시장 전제조건과 제한
주요 요약
- 세계 시장 전망
- 공급과 수요 동향 분석
- 부문별 기회 분석
시장 역학과 전망
- 시장 개요
- 시장 규모
- 시장 역학
- Porter의 Five Forces 분석
주요 시장 인사이트
- 중요 성공 요인
- 경쟁 정도
- 주요 투자 기회
- 시장 생태계
- 시장의 매력 지수(2024년)
- PESTEL 분석
- 거시경제 지표
- 밸류체인 분석
- 가격 분석
산화 스트레스 어세이 시장 규모 : 제품별
산화 스트레스 어세이 시장 규모 : 테스트 유형별
- 시장 개요
- 항산화능 어세이
- 아스코르브산 어세이
- 글루타티온 어세이
- 세포 기반 외인성 항산화물질 어세이
- 간접 어세이
- 지질 기반 어세이
- 핵산 기반 어세이
- 단백질 기반 어세이
- 효소 기반 어세이
- 활성 산소종 기반 어세이
산화 스트레스 어세이 시장 규모 : 기술별
- 시장 개요
- 효소 면역측정법(ELISA)
- 유세포 분석기
- HCS(High Content Screening)
- 무표지 검출
- 현미경 검사
- 크로마토그래피
산화 스트레스 어세이 시장 규모 : 질환 유형별
- 시장 개요
- 심혈관질환
- 당뇨병
- 암
- 호흡기질환
- 기타 질환
산화 스트레스 어세이 시장 규모 : 최종사용자별
- 시장 개요
- 임상 실험실
- 계약연구기관
- 제약 기업 및 바이오테크놀러지 기업
- 학술연구기관
- 화장품 회사
산화 스트레스 어세이 시장 규모
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
- GCC 국가
- 남아프리카공화국
- 기타 중동 및 아프리카
경쟁 정보
- 주요 5개사 비교
- 주요 기업의 시장 포지셔닝(2024년)
- 주요 시장 기업이 채택한 전략
- 시장 최근 동향
- 기업의 시장 점유율 분석(2024년)
- 주요 기업 개요
- 기업 개요
- 제품 포트폴리오 분석
- 부문별 점유율 분석
- 매출 전년대비 비교(2022-2024년)
주요 기업 개요
- Thermo Fisher Scientific(USA)
- Abcam plc(UK)
- Bio-Rad Laboratories, Inc.(USA)
- Merck KGaA(Germany)
- Enzo Life Sciences, Inc.(USA)
- EpiGentek Group, Inc.(USA)
- Promega Corporation(USA)
- Cell Biolabs, Inc.(USA)
- Randox Laboratories Ltd.(UK)
- Biotium, Inc.(USA)
- Biovision, Inc.(USA)
- Abnova Corporation(Taiwan)
- Cayman Chemical Company(USA)
- Enzo Biochem, Inc.(USA)
- Oxford Biomedical Research, Inc.(USA)
- Labcorp Drug Development(USA)
- Bio-Techne Corporation(USA)
- Qiagen N.V.(Germany)
- Becton, Dickinson and Company(BD)(USA)
결론과 추천 사항
LSH
Global Oxidative Stress Assay Market size was valued at USD 945.0 million in 2023 and is poised to grow from USD 1022.49 million in 2024 to USD 1920.78 million by 2032, growing at a CAGR of 8.2% during the forecast period (2025-2032).
The global oxidative stress assay market is on an upward trajectory, fueled by a rising demand for efficient testing methods to evaluate oxidative stress across various diseases. Key drivers of this growth include the increasing prevalence of chronic diseases, heightened awareness surrounding early detection, and technological advancements. Moreover, the shift towards personalized medicine and the integration of oxidative stress assays in drug discovery processes are further propelling market expansion. As notable industry players and continuous research and development efforts bolster the sector, the oxidative stress assay market is set to thrive in the coming years, highlighting its crucial role in modern healthcare diagnostics and treatment strategies.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Oxidative Stress Assay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Oxidative Stress Assay Market Segments Analysis
Global Oxidative Stress Assay Market is segmented by Product, Test Type, Technology, Disease Type, End User and region. Based on Product, the market is segmented into Consumables, Kits, Reagents, Instruments and Services. Based on Test Type, the market is segmented into Antioxidant Capacity Assays, Indirect Assays, Enzyme-based Assays and Reactive Oxygen Species-based Assays. Based on Technology, the market is segmented into Enzyme-linked Immunosorbent Assay (ELISA), Flow Cytometry, High-content Screening (HCS), Label-free Detection, Microscopy and Chromatography. Based on Disease Type, the market is segmented into Cardiovascular Disease, Diabetes, Cancer, Respiratory Diseases and Other Diseases. Based on End User, the market is segmented into Clinical Laboratories, Contract Research Organizations, Pharmaceutical and Biotechnology Companies, Academic Research Institutes and Cosmetic Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Oxidative Stress Assay Market
A significant driver of the global oxidative stress assay market is the rising incidence of chronic diseases coupled with an increased awareness of the need for early diagnosis and preventive healthcare measures. Oxidative stress is a fundamental factor in the development of a variety of conditions, such as cancer, cardiovascular diseases, neurodegenerative disorders, and diabetes. This heightened recognition has spurred demand for oxidative stress assays, which are essential for evaluating and monitoring oxidative stress levels in patients. Furthermore, technological advancements have resulted in the creation of more precise and efficient assays, thereby further propelling market expansion.
Restraints in the Global Oxidative Stress Assay Market
A significant constraint in the global oxidative stress assay market is the elevated costs associated with these tests, which limits their accessibility and uptake, particularly in developing regions. The assays typically necessitate specialized equipment and reagents that can be costly to acquire and sustain. Furthermore, the intricate procedures involved often demand trained personnel, compounding the overall expenses. These challenges are particularly pronounced in resource-limited settings, where healthcare budgets are constrained. Additionally, variabilities in reimbursement policies and insurance coverage for oxidative stress assays across different regions can further affect their affordability, making the high costs a pivotal barrier to widespread adoption and market expansion.
Market Trends of the Global Oxidative Stress Assay Market
The global oxidative stress assay market is witnessing dynamic trends, characterized by heightened awareness among healthcare practitioners and researchers about oxidative stress's implications in various diseases. This awareness is catalyzing demand for oxidative stress assays. Furthermore, advancements in assay technologies are enabling the development of more precise and efficient testing methods, significantly enhancing the market landscape. The escalating prevalence of chronic diseases, including cancer and cardiovascular conditions, is also propelling market growth. Additionally, increased R&D investments, collaborations, and strategic partnerships among leading industry players are fostering innovation and broadening product offerings, positioning the market for sustained growth in the foreseeable future.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2024
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
Global Oxidative Stress Assay Market Size by Product & CAGR (2025-2032)
- Market Overview
- Consumables
- Kits
- Reagents
- Instruments
- Services
Global Oxidative Stress Assay Market Size by Test Type & CAGR (2025-2032)
- Market Overview
- Antioxidant Capacity Assays
- Ascorbic Acid Assays
- Glutathione Assays
- Cell-based Exogenous Antioxidant Assays
- Indirect Assays
- Lipid-based Assays
- Nucleic Acid-based Assays
- Protein-based Assays
- Enzyme-based Assays
- Reactive Oxygen Species-based Assays
Global Oxidative Stress Assay Market Size by Technology & CAGR (2025-2032)
- Market Overview
- Enzyme-linked Immunosorbent Assay (ELISA)
- Flow Cytometry
- High-content Screening (HCS)
- Label-free Detection
- Microscopy
- Chromatography
Global Oxidative Stress Assay Market Size by Disease Type & CAGR (2025-2032)
- Market Overview
- Cardiovascular Disease
- Diabetes
- Cancer
- Respiratory Diseases
- Other Diseases
Global Oxidative Stress Assay Market Size by End User & CAGR (2025-2032)
- Market Overview
- Clinical Laboratories
- Contract Research Organizations
- Pharmaceutical and Biotechnology Companies
- Academic Research Institutes
- Cosmetic Companies
Global Oxidative Stress Assay Market Size & CAGR (2025-2032)
- North America (Product, Test Type, Technology, Disease Type, End User)
- Europe (Product, Test Type, Technology, Disease Type, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product, Test Type, Technology, Disease Type, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product, Test Type, Technology, Disease Type, End User)
- Brazil
- Rest of Latin America
- Middle East & Africa (Product, Test Type, Technology, Disease Type, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2024
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2024
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
- Thermo Fisher Scientific (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abcam plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Rad Laboratories, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Enzo Life Sciences, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- EpiGentek Group, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Promega Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cell Biolabs, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Randox Laboratories Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biotium, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biovision, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Abnova Corporation (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cayman Chemical Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Enzo Biochem, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Oxford Biomedical Research, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Labcorp Drug Development (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bio-Techne Corporation (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Qiagen N.V. (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Becton, Dickinson and Company (BD) (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
